Twin Tree Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-9,200
Closed -$1.07M 1341
2018
Q3
$1.07M Buy
9,200
+6,500
+241% +$733K 0.01% 705
2018
Q2
$341K Buy
+2,700
New +$329K ﹤0.01% 948
2016
Q1
Sell
-2,800
Closed -$304K 1258
2015
Q4
$304K Sell
2,800
-19,300
-87% -$2.21M 0.01% 1003
2015
Q3
$2.21M Buy
22,100
+19,000
+613% +$2.07M 0.06% 326
2015
Q2
$354K Buy
+3,100
New +$376K 0.01% 965
2015
Q1
Sell
-21,400
Closed -$2.58M 1163
2014
Q4
$2.58M Sell
21,400
-200
-0.9% -$26.3K 0.07% 302
2014
Q3
$3.16M Buy
+21,600
New +$3.33M 0.08% 259

Other funds holding CLB

Twin Tree Management's CLB Position: Q4 2018 in Review

Twin Tree Management sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 2,569 shares — an estimated $222K sold.

Twin Tree Management first reported a position in CLB in Q3 2014 and held it in 10 quarters. The position peaked at $1.5M in Q3 2015. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Twin Tree Management reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Twin Tree Management sold 2,569 Core Laboratories shares in Q4 2018, an estimated $222K.
  • Twin Tree Management first reported a position in Core Laboratories in Q3 2014 and held it in 10 quarters.
  • Twin Tree Management's Core Laboratories position peaked at $1.5M in Q3 2015.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Twin Tree Management's 13F filing for Q4 2018, filed 13 Feb 2019.